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Abstract Solid amorphous dispersions are frequently used
to improve the solubility and, thus, the bioavailability of
poorly soluble active pharmaceutical ingredients (APIs).
Spray-drying, a well-characterized pharmaceutical unit
operation, is ideally suited to producing solid amorphous
dispersions due to its rapid drying kinetics. This paper
describes a novel flowchart methodology based on funda-
mental engineering models and state-of-the-art process
characterization techniques that ensure that spray-drying
process development and scale-up are efficient and require
minimal time and API. This methodology offers substan-
tive advantages over traditional process-development
methods, which are often empirical and require large
quantities of API and long development times. This
approach is also in alignment with the current guidance
on Pharmaceutical Development Q8(R1). The methodology
is used from early formulation-screening activities (involv-
ing milligrams of API) through process development and
scale-up for early clinical supplies (involving kilograms of
API) to commercial manufacturing (involving metric tons
of API). It has been used to progress numerous spray-dried
dispersion formulations, increasing bioavailability of for-
mulations at preclinical through commercial scales.
Introduction
Spray-dryingisawidelyusedunitoperationfor pharmaceutical
applications. In addition to its use in preparing solid amorphous
spray-dried dispersions (SDDs), spray-drying is used in
excipient manufacture, pulmonary and biotherapeutic particle
engineering, the drying of crystalline active pharmaceutical
ingredients (APIs), and encapsulation [1].
SDDs are used to increase bioavailability of poorly soluble
APIs.Throughproperformulationandselectionofexcipients,
the SDD technology is applicable to compounds with a broad
range of physiochemical properties [2]. SDD formulations
generally include polymers that are used to increase stability
of the amorphous form in the solid state, to increase the
effective solubility of the drug relative to that of the
crystalline drug form, and to inhibit crystallization of drug
in solution in vivo upon dosing and dissolution [3, 4].
Polymers commonly used in SDDs are povidone, hydrox-
ypropyl methylcellulose, and hydroxypropyl methylcellu-
lose acetate succinate [2, 4]. This article presents a novel
methodology for spray-drying process development that is
applicable to SDD formulations using any of these
polymers.
In common practice, spray-drying process development
is often empirical and is experimentally driven. Traditional
methods often use an iterative design of experiments (DOE)
[5] or statistical treatment of the process parameters and
resulting product attributes [6]. This is often a time-
intensive exercise, requiring large quantities of API, and
the resulting process is often not well understood or
sufficiently robust. Recent efforts have focused on applying
a spectrum of fundamental models to spray-drying process
understanding, ranging from steady-state and equilibrium-
based approaches to rate-based and computational fluid
dynamics (CFD) models [7].
A primary objective of the “cGMPs for the 21st Century”
initiative advocated by the Food and Drug Administration is
to move away from a descriptive approach to one based on
first principles. This paper presents a process-development
approach that rationally combines these fundamental engi-
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process-development timelines and reduce the amount of
API required. It represents a quality by design (QbD)
approach that lays the groundwork for continuous improve-
ment and eventual design-space process regulatory filings.
This approach is in alignment with the current guidance on
Pharmaceutical Development Q8(R1) [8].
This paper is the first of a two-part series. It describes the
basic spray-drying process-development methodology,
which employs a series of screening-scale spray-drying
runs, offline experiments, and fundamental models, leading
to quick and efficient initial process definition. The second
paper in the series will address the methodology for
optimization, scale-up, and definition of a design space
for a commercial-scale spray-drying process.
Spray-Drying Process Overview and Physical Situation
The spray-drying process, shown in Fig. 1, is a well-
established unit operation in the pharmaceutical industry [1].
To manufacture an SDD, a spray solution—which consists of
API and polymer dissolved in a common solvent—is
delivered to an atomizer inside a spray-drying chamber
cocurrently with a hot drying gas. Organic solvents are
typically used to produce SDDs because the API tends to be
poorly water-soluble. Nitrogen drying gas is employed to
provide an inert processing atmosphere when processing
organic solvents. The spray solution is atomized into droplets
using a spray nozzle. Many different types of spray nozzles
can be used including two-fluid, ultrasonic, rotary, and
pressure (or hydraulic) nozzles [9]. Pressure nozzles are
often preferred due to their simplicity, scalability, and ease of
droplet-size tuning [10]. When the spray-solution droplets
contact the hot drying gas, the solvent in the droplets
evaporates, leaving dried SDD particles entrained in the
drying gas that exits the drying chamber. These particles are
collected and then separated from the gas stream, usually by
a cyclone separator.
Most laboratory-scale spray dryers operate in a single-
pass mode where the drying gas is passed through the
chamber only one time before it is vented to the appropriate
waste stream. Many large pilot-scale and production-scale
spray dryers operate in closed-loop or recycle mode where
the solvent-laden drying gas is passed through a condenser,
reheated, and introduced back into the drying chamber. The
optimum process conditions for spray dryers operated in a
recycle mode differ from those operated in a single-pass
mode due to the influence of the solvent vapor in the inlet
drying gas.
Two key control volumes, shown in Fig. 2, can be used
to define the physical situation for spray-drying. The
macroscopic control volume, comprising the entire drying
chamber, defines the overall thermodynamic space based
upon easily measured and monitored spray-drying process
parameters. Mass-balance and energy-balance calculations
can be conducted using the inputs and outputs from the
drying chamber [7, 9]. As described below, these calcu-
lations can be used to predict a continuum of outlet
conditions across a range of inlet parameter values to
characterize the spray-drying operating space and to define
a process design space.
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Fig. 1 General spray-drying equipment configuration
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environment control volume comprises individual droplet
formation, droplet interaction with the drying gas that
immediately surrounds the droplet, and solvent evaporation
to form dry particles. Droplet-drying kinetics is defined in
the droplet-environment control volume. Several key events
occur within this control volume. First, on the scale of
microseconds, droplets are formed via the atomization
process. Second, on the scale of milliseconds, droplets in
the atomization plume contact the hot drying gas and
solvent evaporation begins. Solvent evaporation occurs
quickly, increasing the concentration of solids at the surface
of the droplet and forming a polymer “skin.” The polymer
skin resists solvent evaporation because the solvent must
diffuse through the viscous skin. This entire droplet-drying
process happens quickly; typically, dried particles are
formed within approximately 1 s. Within the context of
process definition, this paper will address experimental and
modeling approaches to gain insight into each of the events
occurring within the droplet-environment control volume,
both on an individual droplet level and across a distribution,
as appropriate.
Understanding the key control volumes is critical to
quantifying the multivariate relationship between product
attributes and process parameters. Use of models and
process-characterization tools aid in the quantitative under-
standing of the key control volumes, leading to rational
definition of process parameters.
Process-Development Flowchart Methodology
Themethodologyinthispaperclearlydemonstratesthatspray-
drying process development based on this flowchart method-
ology requires no more time or API than standard formulation
development. This methodology was conceived while screen-
ing hundreds of APIs as SDDs and progressing more than 25
SDD formulations to the clinic from early stage through late
phase 3 scale-up to commercial scale (metric tons of SDD).
The process-development flowchart methodology (1)
minimizes API usage during process development, (2)
reduces process-development time, and (3) ensures process
robustness during technology transfer to clinical manufac-
turing. This flowchart methodology and associated tools
have been used to achieve a formulation and clinical-supply
process using similar resources to those required for
standard crystalline formulations.
The spray-drying process-development flowchart is
shown in Fig. 3. Each box in the flowchart represents a
process-development tool that is used to define the spray-
drying process. These steps, which begin with the definition
of a robust formulation, are executed in a sequence so that
each step builds from the last, increasing the level of
specificity at each step. The outputs are combined in an
order that initially maximizes the acceptable operating
space and increases process understanding for efficient
process development and future scale-up. Each of the steps
in the flowchart is described in the sections below.
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Fig. 2 Physical situation and key control volumes of the spray-drying process
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In this step, a robust formulation is identified.
Based upon an evaluation of the physicochemical
properties of the API, several initial formulations (general-
ly, two to four) are selected and screened in this step [2]. A
screening-scale spray dryer designed for maximizing yields
from SDD batches of <100 mg is used. This dryer is not
designed to replicate optimized bulk powder properties
(e.g., particle size, density) of larger-scale spray dryers,
but rather is used to match physicochemical properties for
fast, efficient formulation-screening studies. Analogous to
the process-development flowchart methodology, a for-
mulation selection flowchart, comprising predictive
physical-stability models, rapid chemical-stability screens,
and biorelevant in vitro performance tests is key to
selecting a lead SDD polymer and drug-to-polymer ratio.
For the sake of brevity, these will not be addressed in this
paper.
In a QbD approach, formulation and process are linked
through identification of critical-to-quality attributes
(CQAs) and key quality attributes (KQAs) which are
related to critical process parameters and key process
parameters (KPPs). Critical and key quality attributes and
process parameters are defin e di nac r i t i c a l i t ya n dr i s k
assessment [11]. Using this methodology, process devel-
opment is focused on the selection of spray-drying process
parameters that result in the desired KQAs (e.g., particle
size and density) and process performance (e.g., yield)
with minimal impact on CQAs of bioperformance and
stability.
Additional formulation information is gathered during this
step, including preferred spray solvents and spray-solution
solids contents. At the end of this step, a robust formulation
has been selected based upon fundamental physicochemical
properties. Typically, the entire formulation-screening step
can be completed with about 200 to 400 mg of API and, in
some cases, as little as 100 mg of API.
Process Constraints
After a robust formulation has been identified, equipment-
related and formulation-related process constraints are
identified, resulting in definition of the drying-gas flow
rate (Mgas) and drying-gas inlet temperature (Tin).
As part of this methodology, constraints can be placed
on the process based upon equipment limitations (e.g.,
maximum Mgas or Tin values) or formulation properties
(e.g., glass-transition temperature [Tg] or thermal stability).
These constraints can be defined experimentally using
small quantities of SDD produced during the formulation-
screening step.
For example, a hot-bench experiment can be used to
define the maximum Tin value. This involves spreading a
small amount of the SDD across a metal strip with a known
thermal gradient along its length. The powder can be
observed for a time period relevant to a spray-drying run
(e.g., a few hours) for signs of stickiness, melting, and
visual discoloration or “browning.” Conservatively, the
maximum Tin value can be limited to temperatures below
the observed “sticking” or discoloration temperatures of the
SDD. Identifying this constraint minimizes product deposits
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136 J Pharm Innov (2009) 4:133–142on hot spots inside the spray-drying chamber. Alternatively,
spray-drying equipment can be designed to cool hot spots
in the spray-drying chamber, relaxing this constraint [7].
The hot-bench experiment can be performed during
formulation screening and uses approximately 100 to
200 mg of SDD (i.e., 25 to 50 mg of API).
Thermodynamic Design Space
In this step, a thermodynamic operating space is defined to
form an initial design space. This design space is used to
select a drying-gas outlet temperature (Tout) and solution
feed rate (Msoln).
All of the key thermodynamic spray-drying process
parameters and outlet conditions that affect product
attributes can be related through fundamental relationships
by applying a mass and energy balance using the spray-
dryer chamber as a control volume [9]. One or more of
these parameters are often identified as a KPP during a
QbD criticality assessment.
For a spray dryer operating in single-pass mode, the
KPPs and outlet conditions are:
(1) Msoln;
(2) drying-gas flow rate (Mgas);
(3) Tin;
(4) Tout; and
(5) relative saturation (or humidity) of the solvent at
spray-dryer outlet conditions (%RSout).
Simplified equations for conservation of mass and energy
relating all five key thermodynamic process parameters are
shown below.
1
The energy required to vaporize the solvent (i.e., energy
out) is shown as:
DE ¼ Msoln   1   xsolids ðÞ   DHvap ð1Þ
where ∆Hvap is the heat of vaporization and xsolids is the
mass fraction solids in solution.
The energy lost by the drying gas (i.e., energy in) is
shown as:
DE ¼ Mgas   cp   Tin   Tout ðÞ ð 2Þ
where cp is the heat capacity of the drying gas:
Msoln   1   xsolids ðÞ   DHvap
¼ Mgas   cp   Tin   Tout ðÞ : ð3Þ
Solving for Tout:
Tout ¼ Tin  
Msoln   1   xsolids ðÞ   DHvap
Mgas   cp
ð4Þ
and:
Tout ¼ fM soln;Mgas;Tin
  
: ð5Þ
Solving for %RSout at the outlet conditions:
%RSout ¼ 100  
Pchamber
P*Tout
  
 
Msoln 1   xsolids ðÞ =MWsolvent
Msoln 1   xsolids ðÞ =MWsolvent þ Mgas
 
MWgas
  
ð6Þ
where MWsolvent and MWgas are the molecular weights for
the respective species, Pchamber is the absolute pressure in
the spray-dryer chamber, and P*Tout is the equilibrium vapor
pressure of the spray solvent evaluated at Tout.
The equations can be arranged to solve for spray-dryer
outlet conditions as a function of xsolids and Msoln, Mgas, and
Tin.
In conventional methodologies, statistical DOE analysis is
often used to understand the relationship of key process
variables [5, 6]. While such a statistical approach provides
insight into the relationships between process parameters and
product attributes, it is not based in the fundamental physics
of the process and has limited ability to translate across
scales and formulations. The purely statistical approach also
requires large numbers of experiments (and, thus, large
quantities of API) to fully characterize a narrow space.
Rather than purely empirical or statistical methods, the
spray-drying process-development flowchart methodology
relies on the mass and energy balance to calculate outlet
conditions based upon input parameters without the use of
experiments. This fundamental approach allows all five key
spray-drying process parameters to be plotted on the same
multivariate graph. The plot can be generated theoretically
(i.e., without experiments) and the resulting multivariate
graph can be a powerful experimental guide that can be
used to convey an operating or design space.
An example thermodynamic operating space is shown in
Fig.4. The specific drying ratio shown in Fig. 4 is defined as
the mass ratio of solution feed rate to drying-gas flow rate.
Defining the specific drying ratio allows the operating space
for multiple scales of spray dryers to be represented on the
same plot. When considering a single-scale spray dryer, the
drying gas flow rate is typically maximized and held
constant which simplifies the specific drying ratio a single
variable: Msoln. The specific drying ratio is plotted against
Tin, resulting in contours of constant dryer outlet conditions
such as temperature and relative solvent saturation.
1 For spray dryers operating in recycle mode, the relative saturation at
the inlet of the dryer must also be considered. Additional factors—
such as heat loss to the ambient surroundings—would need to be
added if a poorly insulated spray-dryer system is used.
J Pharm Innov (2009) 4:133–142 137A design space within this operating space may be
defined by applying process constraints based upon
equipment limitations and formulation attributes defined
in step 2. Figure 4 shows an example design space that is
optimized for throughput, product density, residual solvent
content, and yield based on the following constraints:
(1) Minimum specific drying ratio (Msoln/Mgas), driven by
target process throughput, is defined based on process-
efficiency requirements. In this example, a minimum
specific drying ratio of 0.06 was defined to ensure that
throughput was sufficient to meet the requirements for
processing time.
(2) Maximum Tout is determined based on thermal
degradation/inactivation of the formulation or
product-property constraints such as SDD specific
density. For this example, the maximum Tout was
defined as 50°C based on previous observations that
SDD specific density did not meet product specifica-
tions above this temperature.
(3) Maximum Tin is defined in step 2. For this example,
the maximum Tin was defined as 120°C to ensure that
the SDD formulation would not stick at the drying-gas
inlet into the spray dryer.
(4) Minimum Tout is determined based upon the relation-
ship of the formulation Tg to the relative saturation at
the dryer outlet.
2 Below this %RSout value, insufficient
drying leads to low collection yields and product
buildup inside the drying chamber caused when “wet”
or “sticky” particles contact the dryer walls. For this
example, an upper limit of 10% RSout was defined due
to the Tg of the SDD formulation used in this example.
The above constraints may be narrowed or additional
constraints may be applied based on specific product
attributes (e.g., particle morphology) that may be desired
(this is discussed in more detail in step 4). For example,
lines of constant product attributes such as SDD bulk
density may be drawn on the thermodynamic operating
space and used to narrow the design space to the target
SDD bulk density.
Drying Kinetics
Up to this point, a robust formulation and four process
parameters (Tin, Msoln, Tout, and Mgas) have been defined. In
this step, target droplet size is defined based on drying-
kinetic limitations.
The thermodynamic operating space described above
defines the process based upon near-equilibrium assump-
tions and does not account for kinetic limitations such as
the drying of large droplets or increased drying resistance
due to film formation at the droplet surface. Drying kinetics
of single droplets can be studied experimentally [12, 13],
but the information provided—while useful—does not
account for the actual conditions in the spray dryer such
as droplet velocity and momentum exchange between the
droplets and the drying gas.
CFD modeling can be used to study drying kinetics at
conditions that are representative of conditions inside the
spray dryer [14, 15]. When modeling the drying of film-
forming solutions, additional algorithms may need to be
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2 This near-equilibrium assumption is usually acceptable at early
stages of process development in single-pass spray dryers. For later-
stage development involving closed-loop spray dryers (where %RSout
is higher due to solvent in the inlet drying gas), further kinetic analysis
is required to define this limit.
138 J Pharm Innov (2009) 4:133–142added to the model to account for the increased drying
resistance due to the formation of a skin or film at the
surface of the droplet. These formulation-specific algorithms
are based on different droplet-drying equations for each of
the drying regimes (e.g., initial solvent evaporation, skin
formation, diffusion of the solvent through the skin) and can
be validated with offline experiments (using placebo
formulations or small quantities of API). In addition to other
methods, these experiments are performed using a thermal
gravimetric analyzer
3 in which a temperature-controlled thin
film of solution is evaporated and its weight monitored over
time. The drying data that are generated are used to estimate
(1) the solids concentration at which a “skin” will form at the
surface during drying and (2) the solvent diffusivity through
the “skin” at a given temperature.
Placebo formulations using the polymer can be success-
fully used to represent the bulk drying behavior due to (1) the
relativeamountofpolymer inthe SDDformulation(typically,
≥50% by weight to active); (2) the high molecular weight of
the polymer, which dominates the rheological properties of
the solution (e.g., viscosity and surface tension); and (3) the
film-forming nature of the polymer, which is largely
responsible for drying phenomena.
Model simulations are conducted across a range of
droplet sizes at the target thermodynamically defined
process parameters. The output of these simulations defines
the maximum target droplet size. Typically, droplet size is
maximized for SDD formulations to produce large particles
(e.g., 50 to 100 µm) with acceptable flow properties for
further processing into dosage forms. Thus, the target
droplet size is generally selected to be the largest that will
result in dry particles exiting the drying chamber without
“wet” or “sticky” particles contacting the dryer walls.
Model outputs shown in Fig. 5 include the temperature
profile in the drying chamber and droplet-drying histories.
If the CFD models and algorithms are validated against
relevant experimental systems, they can be used to simulate
spray-drying runs. Validated CFD models allow multiple
operating conditions to be studied without conducting trial
spray-drying runs with API.
4 CFD modeling approaches
allow rapid optimization of drying kinetics and are
particularly useful during scale-up to production or com-
mercial scale where trial runs can be particularly time-
intensive and API-intensive.
Drying kinetics also define particle morphology and
density for many formulations. SDD morphology is a
strong function of drying kinetics due to the film-forming
properties of commonly used polymers. Particle morphol-
ogy can be related to process parameters using dimension-
less correlations such as the Peclet number [16]. These
correlations can define when a skin is likely to form at the
particle surface during droplet drying. This phenomenon
can also be studied experimentally using an individual
droplet apparatus [12, 13].
Figure 6 shows the effect of drying conditions (i.e., hot/
fast and cold/slow) on particle morphologies. This example,
for demonstration purposes, varies based on solution
properties for a given formulation. In the case of hot/fast
drying, the droplet temperature is near or above the boiling
point of the solvent when droplet skin forms. This causes
the vapor pressure in the particle to keep it “inflated” when
it dries, producing a hollow-sphere morphology. In the case
of cold/slow drying, the droplet temperature is below the
boiling point of the solvent when the droplet skin forms,
causing the particle to collapse into a “raisin” morphology.
These kinetic morphology considerations can be combined
with the thermodynamic operating space defined in step 3
and mapped within the design space.
Drying-kinetic considerations are particularly important
during spray dryer scale-up where additional factors must
be considered [17]. Key scale-up considerations include the
presence of solvent vapor in the inlet drying gas and less
mixing of the droplets and drying gas [18]. In practice, it is
common to see a distribution of particle morphologies.
However, drying parameters may be tuned so that the
majority of the dried particles are of a specific desired
morphology.
Particle Tracks Temperature Contours
Wet droplet
Skinned droplet
Dry particle
Wet dropl
Skinned dro
Dry particle
Fluent Modeling Output: 
Fig. 5 Example CFD simulation output for a specified set of process
parameters, showing temperature contours on the left and particle
tracks on the right, indicating the particle characteristics (wet droplet,
skinned or sticky droplet, or dried particle)
4 The need for model validation cannot be understated. Each model
input (e.g., droplet-size distribution and velocity, drying-gas flow,
velocity pattern, and thermodynamic parameters) and model outputs
should be validated using offline experiments and placebo trial runs.
3 Perkin Elmer TGA 7 thermogravimetric analyzer.
J Pharm Innov (2009) 4:133–142 139Atomization Parameter Selection
In this step, the spray-drying nozzle is selected and
atomization parameters are defined to produce the target
droplet size defined in step 4.
The target droplet size from the atomizer is defined based
on the maximum droplet size defined in step 4 and the desired
particle-size distribution for the product. Droplet size and
solutionsolidscontent directly correlate tothe final size ofthe
dried particle based on the following correlation:
Dparticle ﬃ Ddroplet   3
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
xsolids  
rdroplet
rparticle
s
; ð7Þ
where Dparticle is the diameter of the dried particle, Ddroplet is
the diameter of the droplet, ρparticle is the density of the dried
particle, and ρdroplet is the density of the spray solution.
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Fig. 6 High-speed images of
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Table 1 Spray-drying process-development case study using flow-
chart methodology
Flowchart step Process parameter defined Time
a
(h)
API
a
(mg)
1. Formulation screening/
definition
API/polymer ratio 2 145
Spray solvent
xsolids
2. Process constraints Tin 15 0
b
Mgas
3. Thermodynamic design
space
Msoln 10
Upper and lower limit of
Tout and %RSout
4. Drying kinetics Tout 1
c 0
RSout
5. Atomization parameter
selection
Nozzle size 3 0
Atomization pressure
Atomizer droplet size
6. Verification spray-
drying experiments/SDD
supplies to support tech-
nology transfer
Confirmation that spray-
drying process meets for-
mulation targets
3
d 500
c
Totals 11 645
aRequired for process development
bUsed remaining SDD from step 1
cUsed CFD modeling results for similar formulation from database
dOne or two placebo runs and active run
140 J Pharm Innov (2009) 4:133–142Droplet size is a function of (1) atomizer geometry; (2)
spray-solution attributes (e.g., viscosity and surface ten-
sion); and (3) atomization parameters (e.g., nozzle pressure
and Msoln)[ 19]. Pressure nozzles are preferred for SDD
formulations due to their suitability for viscous film-
forming solutions, robust operation, and scalability. Pres-
sure nozzles have been well studied and characterized [10].
Correlations between droplet size, solution properties, and
nozzle geometry are available in the literature and can be
used to guide initial nozzle selection.
For a specific spray-solution formulation, droplet size can
be measured experimentally using placebo or model solutions
(matching surface tension and viscosity) to confirm nozzle
selection and nozzle operating parameters. Figure 7 shows
example experimental data from a phase Doppler particle
analyzer (PDPA). In this example, two pressure nozzles were
selected based on the desired Msoln value, as defined by the
thermodynamic design space in step 3. The nozzles were
characterized to define nozzle pressure drop and particle size
versus Msoln. These data are then used to select the nozzle
and operating pressure that gives the previously defined
target droplet size and feed rate.
Verification Spray-Drying Experiments (Optional)
At this point, a robust formulation and set of process
parameters has been defined. In this optional step, a spray-
drying trial run is completed to verify the conditions
defined using the process-development flowchart.
Up to this point in the process-development flowchart,
only screening-scale spray-drying runs, offline experiments,
and models have been used, requiring minimal API. This is
illustrated in Table 1, which shows the time and API for
each step of the flowchart for an example case study using
this methodology.
5
In this example, the spray-drying process-development
flowchart methodology was successfully used to rapidly
and efficiently define a robust formulation and spray-drying
process suitable for manufacture of materials for clinical
trials at the pilot scale (approximately 4 kg of SDD per
batch manufactured).
The flowchart methodology provided the following
outcomes:
(1) use of <700 mg of API for all process-development
activities;
(2) rapid definition (<3 weeks, 11 h of total experimental
time) of a robust spray-drying process at pilot scale
(using a Niro Mobile Minor™ spray dryer) using
small-scale experiments and fundamental models;
(3) successful completion of an SDD clinical manufactur-
ing campaign in <3 months from initial process-
development activities; and
(4) replication of key product attributes (e.g., bulk
properties and bioperformance) between development
and clinical scales.
Conclusions
The outcome of the spray-drying process-development flow-
chart methodology allows formulation and process definition
using time and resources similar to those required for
conventional immediate-release crystalline formulations. The
methodology, which is based on fundamental engineering
models and state-of-the-art process-characterization tools, can
be used as an alternative to traditional empirical spray-drying
process-development methods, resulting in streamlined and
robust process development.
This model-based process development represents a
QbD approach that lays the groundwork for continuous
improvement and eventual design-space process regulatory
filings. This approach is in alignment with the current
guidance on Pharmaceutical Development Q8(R1). Many
aspects of this approach can be directly translated to other
atomization/evaporative processes, such tablet-coating and
fluid-bed processes. A similar strategy can also be applied to
many other pharmaceutical-processing unit operations.
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